• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Intersession repeatability of visual function and OCTA metrics in eyes with diabetic macular ischaemia.糖尿病性黄斑缺血患者眼内视觉功能和光学相干断层扫描血管造影(OCTA)指标的学期间重复性
Eye (Lond). 2025 Apr;39(5):906-912. doi: 10.1038/s41433-024-03505-3. Epub 2024 Nov 27.
2
Foveal Avascular Zone Enlargement Correlates with Visual Acuity Decline in Patients with Diabetic Retinopathy.黄斑无血管区扩大与糖尿病视网膜病变患者的视力下降相关。
Ophthalmol Retina. 2024 Dec 13. doi: 10.1016/j.oret.2024.12.015.
3
Macular Capillary Nonperfusion in Eyes With Stable Laser-Treated Proliferative Diabetic Retinopathy.激光治疗稳定的增殖性糖尿病视网膜病变患者眼中的黄斑毛细血管无灌注
JAMA Ophthalmol. 2025 Jan 1;143(1):45-52. doi: 10.1001/jamaophthalmol.2024.5105.
4
Anti-vascular endothelial growth factor for diabetic macular oedema: a network meta-analysis.抗血管内皮生长因子治疗糖尿病性黄斑水肿:一项网状Meta分析。
Cochrane Database Syst Rev. 2017 Jun 22;6(6):CD007419. doi: 10.1002/14651858.CD007419.pub5.
5
Different lasers and techniques for proliferative diabetic retinopathy.用于增殖性糖尿病视网膜病变的不同激光和技术。
Cochrane Database Syst Rev. 2018 Mar 15;3(3):CD012314. doi: 10.1002/14651858.CD012314.pub2.
6
Anti-vascular endothelial growth factor combined with intravitreal steroids for diabetic macular oedema.抗血管内皮生长因子联合玻璃体内注射类固醇治疗糖尿病性黄斑水肿。
Cochrane Database Syst Rev. 2018 Apr 18;4(4):CD011599. doi: 10.1002/14651858.CD011599.pub2.
7
Aflibercept for neovascular age-related macular degeneration.阿柏西普用于治疗新生血管性年龄相关性黄斑变性。
Cochrane Database Syst Rev. 2016 Feb 8;2(2):CD011346. doi: 10.1002/14651858.CD011346.pub2.
8
Anti-vascular endothelial growth factor for diabetic macular oedema: a network meta-analysis.抗血管内皮生长因子治疗糖尿病性黄斑水肿:一项网状Meta分析。
Cochrane Database Syst Rev. 2023 Jun 27;2023(6):CD007419. doi: 10.1002/14651858.CD007419.pub7.
9
Clinical and imaging characteristics associated with foveal neovascularization in proliferative diabetic retinopathy.增殖性糖尿病视网膜病变中与黄斑中心凹新生血管相关的临床和影像学特征。
Graefes Arch Clin Exp Ophthalmol. 2025 Mar;263(3):679-687. doi: 10.1007/s00417-024-06660-1. Epub 2024 Nov 15.
10
Race and Vision Outcomes in Ranibizumab-Treated Participants With Diabetic Macular Edema: A Meta-Analysis.雷珠单抗治疗糖尿病性黄斑水肿患者的种族与视力转归:一项荟萃分析
JAMA Ophthalmol. 2025 Jun 1;143(6):455-461. doi: 10.1001/jamaophthalmol.2024.6371.

本文引用的文献

1
Optical Coherence Tomography Angiography as a Diagnostic Tool for Diabetic Retinopathy.光学相干断层扫描血管造影术作为糖尿病视网膜病变的诊断工具
Diagnostics (Basel). 2024 Feb 2;14(3):326. doi: 10.3390/diagnostics14030326.
2
Assessing the Sensitivity of OCT-A Retinal Vasculature Metrics.评估 OCT-A 视网膜血管测量指标的敏感性。
Transl Vis Sci Technol. 2023 Aug 1;12(8):2. doi: 10.1167/tvst.12.8.2.
3
Intrasession Repeatability of OCT Angiography Parameters in Neurodegenerative Disease.神经退行性疾病中光学相干断层扫描血管造影参数的会话内重复性
Ophthalmol Sci. 2023 Jan 31;3(2):100275. doi: 10.1016/j.xops.2023.100275. eCollection 2023 Jun.
4
Repeatability and Discriminatory Power of Chart-Based Visual Function Tests in Individuals With Age-Related Macular Degeneration: A MACUSTAR Study Report.图表视觉功能测试在年龄相关性黄斑变性患者中的重复性和鉴别力:MACUSTAR 研究报告。
JAMA Ophthalmol. 2022 Aug 1;140(8):780-789. doi: 10.1001/jamaophthalmol.2022.2113.
5
Optical Coherence Tomography Angiography Quality Across Three Multicenter Clinical Studies of Diabetic Retinopathy.光学相干断层扫描血管造影质量在三项糖尿病视网膜病变多中心临床研究中的比较。
Transl Vis Sci Technol. 2021 Mar 1;10(3):2. doi: 10.1167/tvst.10.3.2.
6
Repeatability of Optical Coherence Tomography Angiography Measurements in Patients with Retinal Vein Occlusion.视网膜静脉阻塞患者光学相干断层扫描血管造影测量的可重复性。
Korean J Ophthalmol. 2021 Apr;35(2):159-167. doi: 10.3341/kjo.2020.0143. Epub 2021 Apr 5.
7
Low Luminance Visual Acuity and Low Luminance Deficit in Proliferative Diabetic Retinopathy.增殖性糖尿病视网膜病变中的低亮度视力和低亮度缺陷
J Clin Med. 2021 Jan 19;10(2):358. doi: 10.3390/jcm10020358.
8
Standardization of OCT Angiography Nomenclature in Retinal Vascular Diseases: First Survey Results.OCT 血管造影命名标准化在视网膜血管疾病中的应用:首次调查结果。
Ophthalmol Retina. 2021 Oct;5(10):981-990. doi: 10.1016/j.oret.2020.12.022. Epub 2021 Jan 1.
9
Quantitative optical coherence tomography angiography: A review.定量光学相干断层扫描血管造影:综述。
Exp Biol Med (Maywood). 2020 Feb;245(4):301-312. doi: 10.1177/1535370219899893. Epub 2020 Jan 20.
10
Improved Macular Capillary Flow on Optical Coherence Tomography Angiography After Panretinal Photocoagulation for Proliferative Diabetic Retinopathy.经全视网膜光凝治疗增生性糖尿病视网膜病变后,光学相干断层扫描血管造影显示视网膜毛细血管血流改善。
Am J Ophthalmol. 2019 Oct;206:217-227. doi: 10.1016/j.ajo.2019.04.032. Epub 2019 May 10.

糖尿病性黄斑缺血患者眼内视觉功能和光学相干断层扫描血管造影(OCTA)指标的学期间重复性

Intersession repeatability of visual function and OCTA metrics in eyes with diabetic macular ischaemia.

作者信息

Thottarath Sridevi, Tsai Wei-Shan, Gurudas Sarega, Pearce Elizabeth, Chueng Chui Ming Gemmy, Yamaguchi Taffeta Ching Ning, Sivaprasad Sobha

机构信息

National Institute of Health Research Moorfields Biomedical Research Centre and Clinical Research Facility, Moorfields Eye Hospital, London, UK.

Institute of Ophthalmology, University College London, London, UK.

出版信息

Eye (Lond). 2025 Apr;39(5):906-912. doi: 10.1038/s41433-024-03505-3. Epub 2024 Nov 27.

DOI:10.1038/s41433-024-03505-3
PMID:39604628
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11933375/
Abstract

OBJECTIVE

To estimate inter-session coefficient of repeatability (CR) of visual function and OCTA metrics over 3 months in diabetic macular ischaemia (DMI) in stable laser-treated proliferative diabetic retinopathy (PDR) patients.

METHODS

This prospective study recruited patients with stable PDR for at least 6 months following pan-retinal photocoagulation with visual acuity of at least 54 ETDRS letters. DMI was confirmed on OCTA as FAZ area of at least 0.5 mm or parafoveal capillary dropout in at least one quadrant if the FAZ area was less than 0.5 mm. Repeatability was assessed at baseline and 3 months by calculating the coefficients of repeatability (CR) and intraclass correlation coefficient (ICC). The Bland Altman (BA) plots including 95% CI bands for the bias (mean difference) and upper and lower limits of agreement (LOA) were used to visualise the agreement of the measurements.

RESULTS

88 eligible eyes of 63 participants were included in the analysis. The CR for best corrected visual acuity (BCVA) was 10.1 ETDRS letters (95% CI 8.5-11.7 ETDRS letters), and for low luminance visual acuity (LLVA) was 12.4 letters (95% CI 10.4-14.4). The ICC for BCVA and LLVA was 0.81 and 0.75 respectively. For Square Root of Foveal Avascular Zone (SQRT-FAZ) area, CR and ICC was 0.043 mm and 1.00 respectively. The Bland-Altman plots suggest that the level of agreement is wider for vascular density (VD) metrics compared to FAZ parameters.

CONCLUSION

We recommend using the FAZ metrics for quantitative measurements of DMI outcomes due to the excellent repeatability of manually corrected FAZ area.

摘要

目的

评估稳定的激光治疗增殖性糖尿病视网膜病变(PDR)患者糖尿病性黄斑缺血(DMI)3个月内视觉功能和光学相干断层扫描血管造影(OCTA)指标的重复性会话间系数(CR)。

方法

这项前瞻性研究招募了全视网膜光凝术后至少6个月且视力至少为54个ETDRS字母的稳定PDR患者。如果黄斑无血管区(FAZ)面积小于0.5mm,则通过OCTA确认DMI为FAZ面积至少0.5mm或至少一个象限的黄斑旁毛细血管缺失。在基线和3个月时通过计算重复性系数(CR)和组内相关系数(ICC)来评估重复性。使用包含偏差(平均差异)的95%置信区间带以及一致性上限和下限(LOA)的布兰德-奥特曼(BA)图来直观显示测量值的一致性。

结果

63名参与者的88只符合条件的眼睛纳入分析。最佳矫正视力(BCVA)的CR为10.1个ETDRS字母(95%置信区间8.5 - 11.7个ETDRS字母),低亮度视力(LLVA)的CR为12.4个字母(95%置信区间10.4 - 14.4)。BCVA和LLVA的ICC分别为0.81和0.75。对于黄斑无血管区面积平方根(SQRT - FAZ),CR和ICC分别为0.043mm和1.00。布兰德-奥特曼图表明,与FAZ参数相比,血管密度(VD)指标的一致性水平更宽。

结论

由于手动校正的FAZ面积具有出色的重复性,我们建议使用FAZ指标对DMI结果进行定量测量。